In this episode of Beatwise The Podcast, I speak with Professor John McMurray, a prominent cardiologist from Glasgow, about the remarkable benefits of Sodium-glucose cotransporter 2 (SGLT2) inhibitors. 

Initially used to treat type 2 diabetes, these medications have shown revolutionary potential in managing heart failure and chronic kidney disease. 

We explore how SGLT2 inhibitors work, their rapid effectiveness, and their well-tolerated nature, especially in elderly patients. We also address common misconceptions and barriers to their use, emphasising the urgent need for broader adoption to improve patient outcomes. 

Episode Highlights:

[00:00] -  Introduction to Beatwise The Podcast

[00:49] -  Understanding SGLT2 Inhibitors

[03:28] -  Benefits of SGLT2 Inhibitors for Heart Failure

[06:32] -  Clinical Trials and Patient Outcomes

[08:31] -  Addressing Barriers and Misconceptions

[21:09] -  Side Effects and Safety of SGLT2 Inhibitors

[28:17] - Efficacy in Elderly and Frail Patients

[32:39] - Conclusion and Final Thoughts

If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.

Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!

Disclaimer:

The content of this podcast is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before making any changes to your diet or health routine.

Hosted on Acast. See acast.com/privacy for more information.